skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i Team - Could you provide an update on the fundamentals of GSY and your opinion as a buy at today's price. Also having checked the INK Insider Report there seems to have been a lot of selling. Could you comment on this as well as total insider holdings. I know that GSY is in the business of lending money but does it also have debt and if so then is it a manageable amount.
Thanks.
Read Answer Asked by Rob on April 13, 2021
Q: I am looking to increase my health exposure. I am looking at TDOC, DOC or VEEV and already have a full position in WELL. Do you prefer one over the other, all 3 or do you have another recommendation in this space?
Thanks for your service!
Read Answer Asked by Ozzie on April 13, 2021
Q: I'm looking at the rebound in these tech and consumer discretionary stocks and wondering whether you have a preference for some of these companies over others. Could you please rank your favourites based on risk/reward to buy now, and would you recommend trading any to exchange for others? I have holdings in most.

Thanks for your thoughtful review.
Read Answer Asked by Peter on April 13, 2021
Q: Hello,

I sold my shares in Alphabet a few months back (which I now regret!) and have some U.S. cash sitting in my RRSP account. I have purchased SBUX and MSFT but want to add some U.S. holdings. I am near retirement, however have a DB pension plan so I can tolerate average to above average risk. I would appreciate your suggestions.

Thank you!
Read Answer Asked by Sue on April 09, 2021
Q: MELI seems to have lost its mojo and I'm looking a stock to complement my tech strong portfolio.

Do you think finances are a good recovery play? Do you like BAC as a finance play?

What sectors companies do you like?

2020 was good to me as i was all in tech.
Time to broaden my selection.
Thanks for all your support.
Read Answer Asked by Mark on April 09, 2021
Q: Hello. Thoughts on this one? How does it stack up to Maxar and do you prefer one over the other? Would you be buyers of either?
Read Answer Asked by Robert on April 09, 2021
Q: CRNC,DOCU,MGNI,NEO,NVO,PLUG,TDOC,FCEL.
is any of this worth keeping/selling?
Thanks a million.
Read Answer Asked by Nizar on April 08, 2021
Q: I made the mistake of buying 200 shares of Ballard @$46.50 a couple of months ago just before it commenced its early-February fall from an all-time high. At the current price (~$30), I am tempted to double down with another 200 shares to bring my avg share price cost to ~$38, representing about 4% of my portfolio, a level with which I am comfortable. Am I nuts, or is BLDP poised to reward my faith and patience over the medium term (5 years)?

Thanks for your insights!
Read Answer Asked by William on April 08, 2021
Q: For a stock price to double in 5 years requires an average gain of about 15% compounded, annually. Would you please rank these 12 stocks in order for the likelihood, in your opinion, they will double in price in the next 5 years. Roughly how many of these 12 would you expect to achieve that target? Assuming no major long term market melt down which would preclude good stock performance over this period. CTS, DCBO, DND, DOO, ECN, GOOS, GSY, KXS, MG, NVEI, PHO, TIXT.
Read Answer Asked by Dan on April 07, 2021
Q: Hi the great team, in the past you have mentioned exceptional growth companies. My guess is that you are referring to revenue and eps growth. Please name 5 of such companies with less risk. Thanks.
Read Answer Asked by victor on April 07, 2021
Q: Is $60 M for three dispensaries in the Philadelphia area a good deal? What sort of revenue could TRUL generate from these dispensaries?

My ‘back of the envelope’ calculations:
o # of dispensaries at end of 2020: 75
o 11 added in the 4th quarter, so lets say ~64 dispensaries made full contributions for 2020 (I have not checked if there were earlier dispensary additions in 2020)
o 2020 total revenue was 521,533,000
o 521,533,000 / 64 = 8,148,953 average revenue / dispensary

So to pay $60M for 3 dispensaries seems a little rich.
I have no idea of the addressable market for these new dispensaries.

Thanks!
Read Answer Asked by Robert on April 07, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!